Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD.
Liora M SchultzKara Lynn DavisAnn WalkushChristina BaggottCourtney EricksonSneha RamakrishnaCatherine AftandilianNorman LacayoHelen Ruth NadelJean OakCrystal L MackallPublished in: Journal for immunotherapy of cancer (2023)
We highlight this case as both peripheral blood MRD and 18F-fluorodeoxyglucose positron emission tomography imaging were more sensitive than standard bone marrow aspirate testing in detecting this patient's post-CAR relapse. Clinical/Biologic Insight: In the multiply relapsed B-ALL setting, where relapse patterns may include patchy medullary and/or EM disease, peripheral blood MRD and/or whole body imaging, may carry increased sensitivity at detecting relapse in patient subsets, as compared with standard bone marrow sampling.
Keyphrases
- peripheral blood
- positron emission tomography
- bone marrow
- computed tomography
- pet ct
- free survival
- mesenchymal stem cells
- pet imaging
- high resolution
- case report
- rheumatoid arthritis
- acute lymphoblastic leukemia
- acute myeloid leukemia
- diffuse large b cell lymphoma
- hodgkin lymphoma
- multiple myeloma
- fluorescence imaging
- photodynamic therapy